Analystreport

Atossa Genetics Inc (NASDAQ: ATOS) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $5.00 price target on the stock.

Atossa Therapeutics, Inc.  (ATOS) 
Last atossa therapeutics, inc. earnings: 11/13 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.atossagenetics.com